Journal
DIGESTIVE DISEASES AND SCIENCES
Volume 67, Issue 1, Pages 177-186Publisher
SPRINGER
DOI: 10.1007/s10620-021-06833-6
Keywords
Barrett’ s esophagus; Screening; Non-endoscopic; Esophageal adenocarcinoma
Categories
Funding
- Medtronic
Ask authors/readers for more resources
This study found that a commercial non-endoscopic cell collection device showed high sample adequacy and good acceptability in a US population. The diagnostic characteristics suggest that non-endoscopic assessment of Barrett's esophagus could be a promising alternative to endoscopy. Further development of this non-endoscopic approach is warranted.
Background Endoscopic screening for Barrett's esophagus (BE) is common, costly, and underperformed in at-risk people. A non-endoscopic cell collection device can be used to collect esophageal cells, enabling BE screening. Aims This study assessed the acceptability and adequacy of a commercial non-endoscopic cell collection device in a US population. Methods Six sites enrolled patients with confirmed BE or heartburn/regurgitation for >= 6 months. Patients underwent administration of the device, consisting of a sponge encapsulated in a capsule. The capsule dwelled in the stomach for 7.5 min and was retracted via an attached suture. An adequate sample was >= 1 columnar cell by H&E staining. Sample quality was rated using a 0-5 scale, with 0 = no columnar cells and 5 = plentiful groups. Trefoil Factor 3 (TFF3) staining was performed. Accuracy was assessed using esophagogastroduodenoscopy (EGD)/biopsy as the gold standard. Results Of 191 patients, 99.5% successfully swallowed the device. Overall sample adequacy was 91% (171/188), with 84% (158/188) high quality. The detachment rate was 2/190 (1%). Overall sensitivity, specificity, and accuracy of the assay with TFF3 staining were 76%, 77%, and 76%. Sensitivity, specificity, and accuracy for >= 3 cm BE were 86%, 77%, and 82%. Asked if willing to repeat the procedure, 93% would, and 65% indicated a preference for the device over EGD. Conclusions This study demonstrated a high rate of sample adequacy and promising acceptability of this non-endoscopic sampling device in a US population. Diagnostic characteristics suggest that non-endoscopic assessment of BE deserves further development as an alternative to endoscopy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available